<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle">
<p class="DocumentTitle"><strong>PLEXION- sulfacetamide sodium and sulfur lotion </strong><br>Brava Pharmaceuticals, LLC<br></p>
<p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. <a href="http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/SelectedEnforcementActionsonUnapprovedDrugs/default.htm">For further information about unapproved drugs, click here.</a></p>
</div>
<h1>Plexion (sodium sulfacetamide 9.8% and sulfur 4.8%) Lotion</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
<h1></h1>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="L75965203-2513-4c42-9399-c1e9783f883c"></a><a name="section-1"></a><p></p>
<p class="First"><span class="Bold">Rx Only</span></p>
<p>FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="L130fceb4-4305-4a2c-afdc-7fb26a741d4a"></a><a name="section-2"></a><p></p>
<h1><span class="Bold">DESCRIPTION:</span></h1>
<p class="First">Each gram contains 98 mg of sodium sulfacetamide and 48 mg of colloidal sulfur in a vehicle consisting of: benzyl alcohol, cetyl alcohol, disodium EDTA, fragrance, glyceryl stearate (and) PEG-100 stearate, magnesium aluminum silicate, PEG-150 distearate, phenoxyethanol, polyethylene glycol 400, purified water, sodium lauryl sulfate, sodium thiosulfate, stearyl alcohol and xanthan gum.</p>
<p>Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Sodium sulfacetamide is C<span class="Sub">8</span>H<span class="Sub">9</span>N<span class="Sub">2</span>NaO<span class="Sub">3</span>S·H<span class="Sub">2</span>O with molecular weight of 254.24. Chemically, sodium sulfacetamide is N-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is:</p>
<p></p>
<p><img alt="structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f4ad79c1-bdac-40aa-af75-476826c7f009&amp;name=structure.jpg"></p>
<p></p>
<p>Sodium sulfacetamide is an odorless, white, crystalline powder with a bitter taste. It is freely soluble in water, sparingly soluble in alcohol, while practically insoluble in benzene, in chloroform and in ether.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="Lec6bf380-4743-4902-ad5e-22b74e03c7c2"></a><a name="section-3"></a><p></p>
<h1><span class="Bold">CLINICAL PHARMACOLOGY:</span></h1>
<p class="First">Sodium sulfacetamide exerts a bacteriostatic effect against sulfonamide sensitive Gram-positive and Gram-negative microorganisms commonly isolated from secondary cutaneous pyogenic <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infections</span>. It acts by restricting the synthesis of folic acid required by bacteria for growth, by its competition with para-aminobenzoic acid. There is no clinical data available on the degree and rate of systemic absorption of this product when applied to the skin or scalp. However, significant absorption of sodium sulfacetamide through the skin has been reported.</p>
<p>The following in vitro data is available but the clinical significance is unknown. Organisms that show susceptibility to sodium sulfacetamide are: Streptococci, Staphylococci, E. coli, Klebsiella pneumoniae, Pseudomonas pyocyanea, <span class="product-label-link" type="condition" conceptid="4235289" conceptname="Salmonellosis">Salmonella</span> species, Proteus vulgaris, Nocardia and Actinomyces. The exact mode of action of sulfur in the treatment of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> is unknown, but it has been reported that it inhibits the growth of <span class="Italics">Propionibacterium <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acnes</span></span> and the formation of free fatty acids.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="L3b82eb8e-867d-4747-a5ce-ec697a353874"></a><a name="section-4"></a><p></p>
<h1><span class="Bold">INDICATIONS AND USAGE:</span></h1>
<p class="First">This product is indicated for use in the topical control of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>, <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> <span class="product-label-link" type="condition" conceptid="136773" conceptname="Rosacea">rosacea</span> and <span class="product-label-link" type="condition" conceptid="137053" conceptname="Seborrheic dermatitis">seborrheic dermatitis</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="Ld7e2fe2f-066d-4a6c-bc94-9e0a4666997a"></a><a name="section-5"></a><p></p>
<h1><span class="Bold">CONTRAINDICATIONS:</span></h1>
<p class="First">This product is contraindicated in persons with known or suspected <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of the ingredients of the product. This product is not to be used by patients with kidney disease.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="L6913653c-f272-4add-b81e-c8c77aefe45a"></a><a name="section-6"></a><p></p>
<h1><span class="Bold">WARNINGS:</span></h1>
<p class="First">Sulfonamides are known to cause <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">Stevens-Johnson syndrome</span> in hypersensitive individuals. <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">Stevens-Johnson syndrome</span> also has been reported following the use of sodium sulfacetamide topically. Cases of drug-induced <span class="product-label-link" type="condition" conceptid="257628" conceptname="Systemic lupus erythematosus">systemic lupus erythematosus</span> from topical sulfacetamide also have been reported. In one of these cases, there was a fatal outcome.<span class="Bold"> KEEP OUT OF THE REACH OF CHILDREN.</span></p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="L59148bdb-1b51-4081-b036-36542e87bf34"></a><a name="section-7"></a><p></p>
<h1><span class="Bold">PRECAUTIONS:</span></h1>
<p class="First"><span class="Bold">FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.</span></p>
<p><span class="Bold">General:</span> Nonsusceptible organisms, including fungi, may proliferate with the use of this preparation.</p>
<p>Although rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to topical sulfonamides. If the use of this product produces signs of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> or other untoward reactions, discontinue use of the preparation. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. Systemic toxic reactions such as <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="435503" conceptname="Hemolytic anemia">acute hemolytic anemia</span>, <span class="product-label-link" type="condition" conceptid="4047773" conceptname="Purpura">purpura</span> hemorrhagica, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">drug fever</span>, <span class="product-label-link" type="condition" conceptid="137977" conceptname="Jaundice">jaundice</span> and <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">contact dermatitis</span> indicate <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved. Systemic absorption of topical sulfonamides is greater following application to large, infected, abraded, denuded or severely burned areas. Under these circumstances, any of the adverse effects produced by the systemic administration of these agents could potentially occur, and appropriate observations and laboratory determinations should be performed. The object of this therapy is to achieve <span class="product-label-link" type="condition" conceptid="135029" conceptname="Peeling of skin">desquamation</span> without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>, but patients should be cautioned about the possibility.</p>
<p><span class="Bold">Information for Patients:</span> Patients should discontinue the use of this product if the condition becomes worse or if a <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span> develops in the area being treated or elsewhere. The use of this product also should be discontinued promptly and the physician notified if any <span class="product-label-link" type="condition" conceptid="4291025" conceptname="Arthritis">arthritis</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">fever</span> or sores in the mouth develop. Avoid contact with eyes, lips and mucous membranes.</p>
<p><span class="Bold">Drug Interactions:</span> This product is incompatible with silver preparations.</p>
<p><span class="Bold">Carcinogenesis, Mutagenesis and Impairment of Fertility:</span> Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed. Chromosomal nondisjunction has been reported in the yeast, Saccharomyces cerevisiae, following application of sodium sulfacetamide. The significance of this finding to the topical use of sodium sulfacetamide in the human is unknown.</p>
<p><span class="Bold">Pregnancy:</span><span class="Italics">Category C</span>. Animal reproduction studies have not been conducted with this product. It is also not known whether this product can affect reproduction capacity or cause fetal harm when administered to a pregnant woman. This product should be used by a pregnant woman only if clearly needed or when potential benefits outweigh potential hazards to the fetus.</p>
<p><span class="Bold">Nursing Mothers:</span> It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when this product is administered to a nursing woman.</p>
<p><span class="Bold">Pediatric Use:</span> Safety and effectiveness in children under the age of 12 years have not been established.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="Lab5fc63b-3a2f-4fc6-9e2d-5beae3fe9ede"></a><a name="section-8"></a><p></p>
<h1><span class="Bold">ADVERSE REACTIONS:</span></h1>
<p class="First">Reports of irritation and <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to sodium sulfacetamide are uncommon. The following adverse reactions, reported after administration of sterile ophthalmic sodium sulfacetamide, are noteworthy: instances of <span class="product-label-link" type="condition" conceptid="141651" conceptname="Stevens-Johnson syndrome">Stevens-Johnson syndrome</span> and instances of local <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> which progressed to a syndrome resembling <span class="product-label-link" type="condition" conceptid="257628" conceptname="Systemic lupus erythematosus">systemic lupus erythematosus</span>; in one case a fatal outcome was reported (see WARNINGS). To report a serious adverse event, call 1-855-899-4237.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="Lba809208-58b6-4a1a-8ca8-0378aeca1677"></a><a name="section-9"></a><p></p>
<h1><span class="Bold">OVERDOSAGE:</span></h1>
<p class="First">The oral LD<span class="Sub">50</span> of sulfacetamide in mice is 16.5 g/kg. In the event of overdosage, emergency treatment should be started immediately.</p>
<p><span class="Bold">Manifestations:</span> Overdosage may cause <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span> and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>. Large oral overdosage may cause <span class="product-label-link" type="condition" conceptid="75004" conceptname="Frank hematuria">hematuria</span>, <span class="product-label-link" type="condition" conceptid="4188213" conceptname="Crystalluria">crystalluria</span> and renal shutdown due to the precipitation of sulfa crystals in the renal tubules and the urinary tract. For treatment, contact your local Poison Control Center or your doctor.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="L0cfbbc18-81ca-4789-a209-f8015f68d98d"></a><a name="section-10"></a><p></p>
<h1><span class="Bold">DOSAGE AND ADMINISTRATION:</span></h1>
<p class="First">Cleanse affected areas. Apply a thin layer to the affected areas with light massaging, 1 to 3 times daily or as directed by a physician.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="Lcf7b63df-4f18-4050-9e2f-aad55ac5b9c4"></a><a name="section-11"></a><p></p>
<h1><span class="Bold">HOW SUPPLIED:</span></h1>
<p class="First">2 oz. (57 g) bottles, <span class="Bold">NDC</span> 57883-405-02<br>10 - 4 g sample tubes, <span class="Bold">NDC</span> 57883-405-04</p>
<p>Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized. Protect from freezing and excessive heat. The product may tend to darken slightly on storage. Slight discoloration does not impair the efficacy or safety of the product. Keep bottle tightly closed.</p>
<p>Occasionally, a slight discoloration of fabric may occur when an excessive amount of the product is used and comes in contact with white fabrics. This discoloration, however, presents no problem, as it is readily removed by ordinary laundering without bleaches.</p>
<p>Manufactured for:<br>Brava Pharmaceuticals, LLC<br>2100 West Loop South<br>Suite 900<br>Houston, TX 77027</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="L5758edce-5249-42a8-b4b5-0b60b6fea3ae"></a><a name="section-12"></a><p></p>
<p class="First"><img alt="label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=f4ad79c1-bdac-40aa-af75-476826c7f009&amp;name=label.jpg"></p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>PLEXION 		
					</strong><br><span class="contentTableReg">sulfacetamide sodium, sulfur lotion</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:57883-405</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SULFACETAMIDE SODIUM</strong> (SULFACETAMIDE) </td>
<td class="formItem">SULFACETAMIDE SODIUM</td>
<td class="formItem">98 mg  in 1 g</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>SULFUR</strong> (SULFUR) </td>
<td class="formItem">SULFUR</td>
<td class="formItem">48 mg  in 1 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>BENZYL ALCOHOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CETYL ALCOHOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>EDETATE DISODIUM</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>GLYCERYL STEARATE SE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>PEG-100 STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM ALUMINUM SILICATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>PEG-150 DISTEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PHENOXYETHANOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POLYETHYLENE GLYCOL 400</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM LAURYL SULFATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM THIOSULFATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>XANTHAN GUM</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">yellow</td>
<td class="formLabel">Score</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:57883-405-02</td>
<td class="formItem">57 g in 1 BOTTLE, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:57883-405-04</td>
<td class="formItem">10  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem"></td>
<td class="formItem">4 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">unapproved drug other</td>
<td class="formItem"></td>
<td class="formItem">09/01/2005</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Brava Pharmaceuticals, LLC
							(078786338)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 5/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>65212f75-df5d-4dac-ae06-469518027570</div>
<div>Set id: f4ad79c1-bdac-40aa-af75-476826c7f009</div>
<div>Version: 1</div>
<div>Effective Time: 20140508</div>
</div>
</div> <div class="DistributorName">Brava Pharmaceuticals, LLC</div></p>
</body></html>
